What is Solace Health?
Solace Health is dedicated to revolutionizing the healthcare experience by providing personalized advocacy and comprehensive support throughout a patient's medical journey. Unlike traditional models, Solace Advocates actively engage with patients, making necessary calls, navigating complex administrative hurdles, and coordinating care across all medical providers. This hands-on approach ensures patients receive the optimal health outcomes they deserve by untangling even the most intricate healthcare challenges through expert communication and strategic intervention.
How much funding has Solace Health raised?
Solace Health has raised a total of $204M across 3 funding rounds:
Series A
$14M
Series B
$60M
Series C
$130M
Series A (2024): $14M with participation from Inspired Capital, Craft Ventures, and Torch Capital
Series B (2025): $60M led by Craft Ventures, SignalFire, Inspiration Capital Partners, Torch Capital, and Menlo Ventures
Series C (2026): $130M supported by Menlo Ventures, Torch Capital, RiverPark Ventures, Inspired Capital, and SignalFire
Key Investors in Solace Health
Menlo Ventures
Menlo Ventures is a venture capital firm investing in early and growth-stage technology companies, with a focus on enterprise software, consumer internet, fintech, and frontier tech. They partner with founders through multiple stages of scale.
Torch Capital
Torch Capital invests in visionary founders leveraging technology to transform consumer and business operations, focusing on early-stage investments in consumer-facing and B2B platforms. Their team comprises experienced entrepreneurs and industry leaders.
SignalFire
SignalFire is a venture capital firm that uses data, AI, and expert support to ignite growth for early-stage teams across sectors like healthtech and fintech. Their proprietary AI platform, Beacon AI, aids in talent acquisition and market intelligence.
What's next for Solace Health?
With its latest major strategic investment, Solace Health is poised for accelerated growth and enhanced service delivery. The substantial capital infusion, totaling $204M, indicates a strong market validation and provides the resources necessary to scale operations, expand its advocate network, and further develop its platform. This funding will likely enable Solace Health to deepen its impact on patient advocacy, potentially exploring new technological integrations to streamline care coordination and broaden its reach within the enterprise healthcare sector. The company's trajectory suggests a focus on solidifying its position as a leader in patient-centric healthcare solutions.
See full Solace Health company page
